Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 2013. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility (PDMR) under UK Disclosure Rules, rather than a financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share option exercises and sales by specific individuals.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details specific share transactions executed on June 18, 2013, by Mr. P C Thomson and his connected person, Mrs. K Thomson.
Management Commentary and Risks
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this filing. The document is a statutory disclosure of insider trading activity compliant with Rule 12g3-2(b) and Disclosure Rule 3.1.4R(1)(a) and (c).
Important Facts for Investors
- Transaction Type: The filing reports the exercise of share options and immediate sale of shares by a PDMR and a connected person.
- Key Individual: Mr. P C Thomson exercised options granted between 2003 and 2010, selling a total of 46,170 shares.
- Connected Person: Mrs. K Thomson exercised options granted between 2003 and 2010, selling a total of 11,977 shares.
- Transaction Prices: Shares were sold at prices ranging approximately between £16.775 and £16.815, significantly higher than the exercise prices which ranged from £11.23 to £14.88.
- Financial Data: This filing contains no corporate financial results; investors should refer to Form 20-F or quarterly earnings releases for financial metrics.